KLAS Contact
Contact KLAS
Contact KLAS
2023 BEST IN KLAS
Preferences
Related Series
Related Segments
Related Articles
CMS Payer Interoperability 2022
An Early Look at Purchase Decisions and Vendor Performance in a New Market
Author
Joe VanDeGraaff
Author
Jennifer Hickenlooper
Author
Ruirui Sun
Current Time Inside Cache Tag Helper: 12/1/2023 4:48:19 PM and Model.reportId = 1950
CMS recently issued a new regulation stipulating that CMS-regulated payers must be able to securely store and share patient data under the HL7 FHIR standard. To achieve this, organizations use CMS payer interoperability products, which usually provide capabilities such as patient access APIs, provider directory APIs, and payer-to-payer data exchange. Health plans and state agencies are evaluating how well technology vendors’ existing or newly developed solutions can help them stay compliant with the new CMS requirements. This report is KLAS’ first to validate the purchase decisions and customer experience of some of the vendors in this area.if you don't have a login, getting started is easy.
Key Findings:
- 1upHealth, Edifecs, and Smile CDR See Strong Early Traction
- Cognizant and Change Healthcare Already Up for Replacement
- Provider-Sponsored Health Plans Often See InterSystems & Epic as Viable Choices
- Early Performance Insights: 1upHealth Customers Highlight CMS Expertise & Smile CDR Customers Satisfied with Technology; Respondents across All Vendors Experience Bumpy Implementations
Writer
Sarah Hanson
Designer
Madison Moniz
Project Manager
Andrew Wright
This material is copyrighted. Any organization gaining unauthorized access to this report will be liable to compensate KLAS for the full retail price. Please see the KLAS DATA USE POLICY for information regarding use of this report. © 2023 KLAS Research, LLC. All Rights Reserved. NOTE: Performance scores may change significantly when including newly interviewed provider organizations, especially when added to a smaller sample size like in emerging markets with a small number of live clients. The findings presented are not meant to be conclusive data for an entire client base.